Market Overview
Global
Medical High-Pressure Syringe Market is projected to reach
USD 2,036.6 Million by the end of 2024 and grow exponentially until reaching an anticipated
value of USD 3,864.2 Million in 2033 at an anticipated compound annual
growth rate of 7.4%.
High-pressure syringes are designed specifically to withstand high-pressure applications in life sciences, medical sciences and process control industries, proving excellent resistance even to aggressive liquids. Constructed from stainless steel or polycarbonate material and featuring thumb and hand rings or grips to facilitate ease of use for both injection and aspiration modes.
A medical high-pressure syringe is a type of high-pressure syringe used for rapidly and forcefully infusing contrast media, medications or other fluids into an application such as medical procedures requiring rapid injection of contrast media or fluids under high pressures - making this type syringe essential in these procedures.
The US Medical High-Pressure Syringe Market
The US Medical High-Pressure Syringe Market are projected to reach USD 608.4 Million by the end of 2024 and grow steadily to reach a total value of USD 1114.0 Million by 2033 with an expected compound annual compounded annual growth rate of 7.0 %.
Rising chronic disease prevalence necessitates advanced diagnostic imaging and therapeutic procedures in order to effectively address their burden, increasing demand for high-pressure syringes. Furthermore, technological advancements such as CT/MRI fuel market expansion further.
There has been an impressive shift towards more advanced materials like polycarbonate and stainless steel to enhance durability and resistance against aggressive fluids. Furthermore, ergonomic designs of syringes have become more widely adopted to increase user comfort and control.
Key Takeaways
- Market Growth: The Global Multi-Channel Order Management Market is expected to grow by USD 1,692.6 million, at a CAGR of 7.4 %, during the forecasted period i.e. from 2025 to 2033.
- Market Definition: A medical high-pressure syringe is a device used to inject fluids or contrast agents into the body at high pressure.
- Material Analysis: In terms of materials, plastic syringe is predicted to lead the global market with a high revenue share of 44.9% in 2024.
- Product Type Analysis: 5 to 10 ml is predicted to lead the global market size with the largest revenue share by the end of 2024.
- Application Analysis: Hospitals are anticipated to dominate the market with the largest revenue share of 43.7% by the end of 2024.
- Regional Analysis: North America is predicted to dominate the medical high-pressure syringe market with the highest market share of 35.1 % in 2024.
Use Cases
- Contrast Media Injection in Imaging Procedures: Medical high-pressure syringes are used in injecting contrast media during imaging procedures like CT scans, MRI, and angiography. They ensure the contrast agent is delivered quickly & uniformly, improving the quality of the images for accurate diagnosis.
- Cardiovascular Procedures: These syringes are used in operations such as angioplasty and cardiac catheterization to instigate fluids and medications into the heart or blood arteries.
- Power Injection for Radiological Examinations: Injector-pressured syringes are used to force injectors for administering iodine-based contrast solutions during a radiological procedure.
- Drug Delivery in Critical Care: In cases of intensive care unit, high-pressure syringes are being used for the timely delivery of drugs and fluids which are essential for the life of the patient. They allow fast and regulated release which is very important in emergency and Intensive care.
Market Dynamic
Drivers
Impact of Chronic Disease PrevalenceMedical high-pressure syringes and their markets are experiencing a growth rate boost due to various medical procedures such as angiography, contrast imaging, and all other diagnostic and therapeutic procedures. An increase in the prevalence of chronic diseases such as cardiovascular diseases, cancer, and other conditions that necessitate the employment of sophisticated diagnostic/therapeutic medical equipment boosts the demand for dependably & effectively functional high-pressure syringes hence promoting growth.
Technological Innovations
Continuous improvement in healthcare leaves room for improvement in the development of high-pressure syringes which are very important in many sensitive procedures in the medical field. The advancement in the field of syringes that allow better control of pressure and the use of automated methods aids in delivering the contrast media efficiently during imaging procedures which in turn enhances the accuracy of diagnostic tests and thus the imaging outcomes of the patients.
Restraints
Regulatory Challenges
The medical high-pressure syringe market faces significant regulatory challenges that can hinder market growth. These regulations ensure the safety, efficacy, and quality of medical devices. Compliance involves rigorous testing, documentation, and certification processes, which can be time-consuming and costly, thus, obstructing the growth of the market.
High Initial Investment Costs
The medical high-pressure syringe market requires substantial initial investments in technology and infrastructure, posing a barrier to new entrants. Developing high-pressure syringes involves advanced manufacturing techniques, specialized equipment, and stringent quality control measures.
Opportunities
Globalization of Business
There is a growing requirement for standardized, high-quality medical equipment, including high-pressure syringes as the healthcare systems and medical practices converge globally. This globalization creates an opportunity for this market through regulatory harmonization, making it easier for companies to introduce their products to multiple markets and thus accelerating the growth and distribution of medical high-pressure syringes globally.
Trends
Customization and Personalization
Manufacturers of the medical high-pressure syringe market are focusing on the customization and personalization of their products to cater to specific medical requirements and patient needs. It ensures that the syringes can be adapted for a wide range of procedures, from angiography to many diagnostic and therapeutic interventions, improving overall efficiency and patient outcomes.
Digital Transformation
The adoption of digital platforms is transforming the medical high-pressure syringe market by streamlining operations and improving overall efficiency. It improves supply chain management through better inventory tracking, demand forecasting, and real-time monitoring of product availability. These advancements ensure that healthcare providers have timely access to high-pressure syringes, reducing delays and improving patient care.
Research Scope and Analysis
By Material
Plastic syringes are projected to lead the medical high-pressure syringe market with a revenue share of 44.9 % by 2024, due to being cost-effective & affordable options for healthcare providers. Plastic's versatility offers an abundance of syringe designs suitable for meeting many medical needs, from simple injections to complex high-pressure applications. These lightweight syringes are easy to use & reduce hand fatigue for healthcare professionals when performing repetitive tasks.
Furthermore, their resistance to breakage makes them superior compared to glass or metal options. Further, disposable plastic syringes help minimize injury and impurity risks during medical procedures, providing safer care. Also, single-use syringes provide an infection control solution by significantly lowering cross-contamination risk between patients. Thanks to advances in plastic materials that improve chemical resistance, they can handle various medications & solutions without degradation for improved chemical resistance.
Metal syringes are known for their durability & precision. They are used in specialized fields, like dentistry or veterinary medicine, where high-pressure application and repeated use are necessary. Glass Syringes are normally used in the healthcare sector due to their superior chemical inertness properties and are less favored due to their fragility and higher cost. They are used in limited specific applications where material interaction is a critical concern.
By Product Type
The 5 to 10 ml segment is expected to lead the medical high-pressure syringe market with a high revenue share in 2024, due to its extensive use across a wide range of medical applications. This amount offers a balance of capacity & versatility, making it a preferred choice for many healthcare providers. They often dominate the market due to their broad utility and frequent use in everyday medical practices. It is often used to administer medications, vaccines, and certain diagnostic tests.
These are required in many diagnostic and therapeutic procedures like contrast agent injections for imaging, medication administration in emergency settings, and routine injections in healthcare settings.
Above 10 ml syringes are used for high-volume injections, intravenous drug delivery, and in some surgical or diagnostic procedures. It is used in procedures like contrast-enhanced computed tomography and magnetic resonance imaging (MRI), where a significant amount of contrast agent is required.
Meanwhile, up to 5 ml syringes are used for precise applications where a small volume of fluid is needed. It includes injections for pediatric patients, certain types of diagnostic imaging procedures, and administration of medication where precise dosing is critical.
By End User
Hospitals are expected to dominate the medical high-pressure syringe market with a high revenue share of 43.7% in 2024, due to its their comprehensive range of medical services and the high volume of procedures requiring these syringes. It performs many diagnostic imaging, including CT & MRI scans, which frequently utilize high-pressure syringes for administering contrast agents. Moreover, hospitals handle many emergencies, surgeries, and treatments where precise and controlled fluid administration is critical.
The extensive use of high-pressure syringes in these diverse and high-demand settings contributes significantly to their dominance in the market. Clinics are expected to show notable growth due to their smaller scale compared to hospitals, which still represent a significant segment of the market. They provide important healthcare services, including routine check-ups, diagnostic tests, & minor surgical procedures. High-pressure syringes are used in clinics for administering medications, performing diagnostic imaging, & conducting minor treatments.
The other segments include many healthcare settings like diagnostic imaging centers, ambulatory surgical centers, research laboratories, and home healthcare services. Diagnostic imaging centers use high-pressure syringes extensively for contrast administration while ambulatory surgical centers use them extensively during various surgical procedures.
The Medical High-Pressure Syringe Market Report is segmented based on the following
By Material
- Plastic Syringes
- Glass Syringes
- Metal Syringe
By Product Type
- Up to 5 ml
- 5ml to 10 ml
- Above 10 ml
By End User
Regional Analysis
North America is anticipated to lead the overall size of the medical high-pressure syringe market with a market
share of 35.1% in 2024. This dominance is because it has well-developed healthcare that comprises hospitals, clinics, and diagnostic centers. The complex facility uses high-pressure syringes, especially for operations that involve the accurate & effective administration of contrast agents applying imaging techniques such as CT & MRI.
This region has also enjoyed the presence of technological leaders especially in the manufacturing of advanced medical devices. Business entities within this region are manufacturing technologically advanced and quality medical equipment, High-Pressure Syringes inclusive.
This innovation enhancement is backed by heavy spending on research and development, thus creating a flow of fresh products and upgraded versions into the system. In addition, such element as the growing amount of health insurance coverage and reimbursement policies leads to the availability of advanced medical procedures to a larger population in this area.
Europe
- Germany
- The U.K.
- France
- Italy
- Russia
- Spain
- Benelux
- Nordic
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- ANZ
- ASEAN
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of Latin America
Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
- Israel
- Egypt
- Rest of MEA
Competitive Landscape
Global Medical High-Pressure Syringe market is characterized by intense competition, with numerous large and small players offering products and services to domestic and international markets. Major players operating in the market are adopting strategies such as innovating their products and services and engaging in mergers and acquisitions to expand the functionality of their product portfolios and maintain competitiveness.
Emerging players and regional manufacturers are gaining traction by offering cost-effective solutions and targeting niche segments. These companies often focus on local markets, providing customized products that meet regional healthcare requirements.
Some of the prominent players in the Global Medical High-Pressure Syringes market are
- B.Braun
- Coeur
- Bayer
- Medtronics
- MedNet
- Comed
- Kemper Medical, Inc.
- Chemyx, Inc.
- KD Scientific Inc.
- Medline Industries, Inc.
- BD (Becton, Dickinson, and Company)
- Others
Recent Development
- In September 2024, BD a prominent global medical technology firm, uncovered a new generation of glass pre-fillable syringes (PFS), BD EffivaxTM Glass Prefillable Syringe which is designed in collaboration with leading pharmaceutical companies to meet the complex & evolving needs of vaccine manufacturing.
- In November 2023, Medtronic plc revealed that the U.S. Food and Drug Administration (FDA) has approved the Symplicity Spyral™ renal denervation (RDN) system, also referred to as the Symplicity™ blood pressure procedure, for hypertension treatment.
- In November 2023, Terumo India, the Indian arm of Terumo Corporation announced the launch of the Insulin Syringe, a Sterile delivery device for patients requiring regular insulin injections, thereby raising the bar for patient comfort and therapy compliance.
- In September 2024, B. Braun Medical Inc. (B. Braun), a prominent leader in infusion therapy and pain management, announced its acquisition of Starboard Medical, Inc.'s Clik-FIX catheter securement device portfolio. This acquisition strengthens B. Braun’s dedication to advancing innovation in products and programs, to improve patient experiences and outcomes in peripheral intravenous (IV) therapy.
Report Details
| Report Characteristics |
| Market Size (2024) |
USD 2,036.9 Mn |
| Forecast Value (2033) |
USD 3,864.2 Mn |
| CAGR (2024-2033) |
7.4% |
| Historical Data |
2018 – 2023 |
| The US Market Size (2024) |
USD 608.4 Mn |
| Forecast Data |
2025 – 2033 |
| Base Year |
2023 |
| Estimate Year |
2024 |
| Report Coverage |
Market Revenue Estimation, Market Dynamics, Competitive Landscape, Growth Factors and etc. |
| Segments Covered |
By Material (Plastic Syringes, Glass Syringes, and Metal Syringes), By Product Type (Up to 5 ml , 5ml to 10 ml, and Above 10 ml ), By End User (Hospital, Clinics, and Others) |
| Regional Coverage |
North America – The US and Canada; Europe – Germany, The UK, France, Russia, Spain, Italy, Benelux, Nordic, & Rest of Europe; Asia- Pacific– China, Japan, South Korea, India, ANZ, ASEAN, Rest of APAC; Latin America – Brazil, Mexico, Argentina, Colombia, Rest of Latin America; Middle East & Africa – Saudi Arabia, UAE, South Africa, Turkey, Egypt, Israel, & Rest of MEA
|
| Prominent Players |
B.Braun, Coeur, Bayer, Medtronics, MedNet, Comed, Kemper Medical, Inc., Chemyx, Inc., KD Scientific Inc., Medline Industries, Inc., BD (Becton, Dickinson, and Company), and Other Key Players |
| Purchase Options |
We have three licenses to opt for: Single User License (Limited to 1 user), Multi-User License (Up to 5 Users) and Corporate Use License (Unlimited User) along with free report customization equivalent to 0 analyst working days, 3 analysts working days and 5 analysts working days respectively. |
Frequently Asked Questions
The Global Medical High-Pressure Syringe Market size is estimated to have a value of USD 2,036.9 million in 2024 and is expected to reach USD 3,864.2 billion by the end of 2033.
North America is expected to be the largest market share for the Global Medical High-Pressure Syringe Market with a share of about 35.1% in 2024.
Some of the major key players in the Global Medical High-Pressure Syringe Market are B.Braun, Coeur, Bayer, Medline, and many others.
The market is growing at a CAGR of 7.4 percent over the forecasted period.
The US Medical High-Pressure Syringe Market size is estimated to have a value of USD 608.4 million in 2024 and is expected to reach USD 1114.0 million by the end of 2033.